Patents by Inventor Moises Rivera-Bermudez

Moises Rivera-Bermudez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GASTROINTESTINAL BYPASS DEVICES AND RELATED METHODS OF USE
    Publication number: 20210386572
    Abstract: A bypass device may include an elongate member extending from a proximal end toward a distal end, and a proximal opening and a distal opening coupled to one another by a lumen disposed through the elongate member. The bypass device also may include at least one port extending through a side surface of the elongate tubular member, wherein at least a portion of the bypass device may be bioabsorbable.
    Type: Application
    Filed: August 31, 2021
    Publication date: December 16, 2021
    Applicant: Boston Scientific Scimed, Inc.
    Inventors: John Allen HINGSTON, Niklas ANDERSSON, Moises RIVERA-BERMUDEZ, John B. GOLDEN, Andrew CALABRESE, Leah MCELHANEY
  • Gastrointestinal bypass devices and related methods of use
    Patent number: 11129739
    Abstract: A bypass device may include an elongate member extending from a proximal end toward a distal end, and a proximal opening and a distal opening coupled to one another by a lumen disposed through the elongate member. The bypass device also may include at least one port extending through a side surface of the elongate tubular member, wherein at least a portion of the bypass device may be bioabsorbable.
    Type: Grant
    Filed: June 2, 2017
    Date of Patent: September 28, 2021
    Assignee: BOSTON SCIENTIFIC SCIMED, INC.
    Inventors: John Allen Hingston, Niklas Andersson, Moises Rivera-Bermudez, John B. Golden, Andrew Calabrese, Leah McElhaney
  • GASTROINTESTINAL BYPASS DEVICES AND RELATED METHODS OF USE
    Publication number: 20170348129
    Abstract: A bypass device may include an elongate member extending from a proximal end toward a distal end, and a proximal opening and a distal opening coupled to one another by a lumen disposed through the elongate member. The bypass device also may include at least one port extending through a side surface of the elongate tubular member, wherein at least a portion of the bypass device may be bioabsorbable.
    Type: Application
    Filed: June 2, 2017
    Publication date: December 7, 2017
    Inventors: John Allen Hingston, Niklas Andersson, Moises Rivera-Bermudez, John B. Golden, Andrew Calabrese, Leah McElhaney
  • Vitamin D receptor antagonists and their use in treating asthma
    Patent number: 7915242
    Abstract: Various compounds such as those having the formula I and XIV where the variables have the values described herein antagonize the vitamin D receptor and are useful in treating conditions such as asthma and in preparing medicaments for use in antagonizing the vitamin D receptor or treating conditions such as asthma
    Type: Grant
    Filed: February 16, 2005
    Date of Patent: March 29, 2011
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Hector F. DeLuca, Rafal Barycki, Moisés A. Rivera-Bermúdez, Lori A. Plum, Margaret Clagett-Dame
  • Pulmonary delivery of 1alpha,25-dihydroxyvitamin D3 and co-administration of parathyroid hormone or calcitonin
    Publication number: 20080031957
    Abstract: Pharmaceutical pulmonary compositions, methods of delivery to the lungs of a human and methods of treatment thereof. Pharmaceutical formulations including 1?,25-dihydroxyvitamin D3, an alcohol such as ethanol, and a polyol such as propylene glycol. Another pharmaceutical pulmonary formulation includes 1?,25-dihydroxyvitamin D3 and dry bulking powder, which is used in a dry powder inhaler. Another pharmaceutical formulation includes 1?,25-dihydroxyvitamin D3 and an aerosol propellant, which is used in a metered dose inhaler. The pharmaceutical pulmonary formulations may include a second active pharmaceutical ingredient such as calcitonin or a N-terminal peptide fragment of parathyroid hormone consisting of the first 34 to 38 amino acids of SEQ ID No. 1. Pulmonary delivery of the formulations efficaciously increase serum calcium levels in mammals, manage hypocalcemia, treat calcium metabolic disorder and reduce elevated parathyroid hormone levels.
    Type: Application
    Filed: May 15, 2007
    Publication date: February 7, 2008
    Inventors: Hector DeLuca, Margaret Clagett-Dame, Lori Plum, Moises Rivera-Bermudez
  • Vitamin D receptor antagonists and their use in treating asthma
    Publication number: 20050182033
    Abstract: Various compounds such as those having the formula I and XIV where the variables have the values described herein antagonize the vitamin D receptor and are useful in treating conditions such as asthma and in preparing medicaments for use in antagonizing the vitamin D receptor or treating conditions such as asthma
    Type: Application
    Filed: February 16, 2005
    Publication date: August 18, 2005
    Inventors: Hector DeLuca, Rafal Barycki, Moises Rivera-Bermudez, Lori Plum, Margaret Clagett-Dame